Compugen (CGEN) Shareholder's Equity Growth (1y) (2010 - 2025)
Compugen (CGEN) Shareholder's Equity Growth (1y) (2010 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Compugen |
189.59 Mn |
97.83 Mn |
352,000.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
87.08% |
| Dec 31, 2024 |
-16.24% |
| Dec 31, 2023 |
-15.60% |
| Dec 31, 2022 |
-27.19% |
| Dec 31, 2021 |
-10.93% |
| Dec 31, 2020 |
212.58% |
| Dec 31, 2019 |
2.89% |
| Jun 30, 2015 |
-2.77% |
| Mar 31, 2015 |
1.00% |
| Dec 31, 2014 |
232.78% |
| Sep 30, 2014 |
293.32% |
| Jun 30, 2014 |
373.73% |
| Mar 31, 2014 |
359.44% |
| Dec 31, 2013 |
80.44% |
| Sep 30, 2013 |
44.62% |
| Jun 30, 2013 |
-5.36% |
| Mar 31, 2013 |
2.36% |
| Dec 31, 2012 |
-9.75% |
| Sep 30, 2012 |
-15.81% |
| Jun 30, 2012 |
-15.22% |
